Skip to main content
Premium Trial:

Request an Annual Quote

OGT, Emory Genetics Lab Collaborate on New CGH Arrays

NEW YORK (GenomeWeb News) – Oxford Gene Technology said today that it has been working with Emory Genetics Laboratory to develop a menu of comparative genomic hybridization arrays focused on a variety of genetic disorders.

Together, the Oxford, UK-based company and EGL have designed more than 20 such chips, which enable the detection of copy number variants in genes associated with cardiovascular, inherited eye, intellectual disability, and neuromuscular disorders, as well as a range of inherited cancers.

OGT is also making these new research tools available as catalog products under the name CytoSure Molecular Arrays. The company said it also welcomes custom projects based on these existing array designs, calling them in a statement an "ideal complement to DNA sequencing."

EGL Executive Director Madhuri Hegde will be discussing her lab's partnership with OGT and the new chips during a workshop at the America College of Medical Genetics and Genomics' annual meeting, which will be held in Nashville, Tenn., later this month.

Hegde discussed EGL's combined use of CGH arrays and sequencing with BioArray News in November.